Teva Pharmaceutical Industries Ltd
Industry and Market Reports

 
URL: http://www.tevapharm.com  

List of associated reports

Below is a list of reports where Teva Pharmaceutical Industries Ltd is mentioned. The list of reports for the company is categorised by Industry, Region and report type. This categorisation along with the number of reports in each category is shown in the region on the left.

Many of the reports mention companies other than Teva Pharmaceutical Industries Ltd in the same report. This provides an indication of potential competitors or associated to Teva Pharmaceutical Industries Ltd. The relevance ranking is a measure of how many times both companies are mentioned in the same reported. These associated companies can me clicked to find out more about the company.

View Report: Research and Experts Market Report: Female Contraception - Pipeline Review, H2 2016

Female Contraception - Pipeline Review, H2 2016


2016-12-30
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Female Contraception – Pipeline Review, H2 2016, provides an overview of the Female Contraception (Women's Health) pipeline landscape.

Contraception (birth...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8847IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8847IDB
  • View Report: Research and Experts Market Report: Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016

    Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016" provides an overview of Eosinophilic Esophagitis clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3922CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3922CTIDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Myelocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Myelocytic Leukemia (Oncology) pipeline landscape.

    Acute myelocytic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8869IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8869IDB
  • View Report: Research and Experts Market Report: Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2016

    Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Immunodeficiency Virus Infections (AIDS) – Pipeline Review, H2 2016, provides an overview of the Human Immunodeficiency Virus Infections (AIDS) (Infectious...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8867IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8867IDB
  • View Report: Research and Experts Market Report: Parkinson

    Parkinson's Disease - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Parkinson's Disease – Pipeline Review, H2 2016, provides an overview of the Parkinson's Disease (Central Nervous System) pipeline landscape.

    Parkinson'...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8863IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8863IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H2 2016

    Neuropathic Pain - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain – Pipeline Review, H2 2016, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape.

    Neuropathic pain, or...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8861IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8861IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H2 2016

    Prostate Cancer - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Prostate Cancer (Oncology) pipeline landscape.

    Prostate cancer is a form of cancer that...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8860IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8860IDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Pipeline Review, H2 2016

    Multiple Sclerosis - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis – Pipeline Review, H2 2016, provides an overview of the Multiple Sclerosis (Central Nervous System) pipeline landscape.

    Multiple sclerosis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8845IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8845IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease) – Pipeline Review, H2 2016, provides an overview of the Multiple Myeloma (Kahler Disease) (Oncology) pipeline landscape.

    Multiple...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8844IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8844IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H2 2016, provides an overview of the Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline landscape.

    Kidney...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8816IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8816IDB
  • View Report: Research and Experts Project Profile: TEVA - Ra

    TEVA - Ra'anana Headquarters Development - Israel - Construction Project Profile


    2016-11-30
    Timetric's "TEVA – Ra'anana Headquarters Development – Israel - Construction Project Profile" is a crucial resource for industry executives and anyone looking to access key information about the TEVA – Ra'anana...
  • Project Profile
  • Manufacturing and Construction
  • Israel
  • $75.00
  • Report 00RV-CIC189287PP has a star rating of 3.9 out of 5
  • Go to More information on Report 00RV-CIC189287PP
  • View Report: Research and Experts Market Report: Tardive Dyskinesia Global Clinical Trials Review, H2, 2016

    Tardive Dyskinesia Global Clinical Trials Review, H2, 2016


    2016-11-22
    GlobalData's clinical trial report, “Tardive Dyskinesia Global Clinical Trials Review, H2, 2016" provides an overview of Tardive Dyskinesia clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3913CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3913CTIDB
  • View Report: Research and Experts Market Report: Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H2, 2016

    Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H2, 2016" provides an overview of Tachycardia (Tachyarrhythmias) clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3888CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3888CTIDB
  • View Report: Research and Experts Market Report: Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2016

    Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2016


    2016-12-01
    GlobalData's Medical Devices sector report, “Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2016" provides an overview of Transdermal Drug Delivery currently in pipeline stage.

    The report provides comprehensive information...

  • Market Report
  • Pharmaceuticals
  • Global
  • $4,000.00
  • Report 05IC-GDME0290EPD has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDME0290EPD
  • View Report: Research and Experts Market Report: Angiopoietin 1 Receptor (Endothelial Tyrosine Kinase or Tunica Interna Endothelial Cell Kinase or Tyrosine Kinase With Ig And EGF...

    Angiopoietin 1 Receptor (Endothelial Tyrosine Kinase or Tunica Interna Endothelial Cell Kinase or Tyrosine Kinase With Ig And EGF Homology Domains 2 or Tyrosine Protein Kinase Receptor TEK or Tyrosine Protein Kinase Receptor TIE 2 or p140 TEK or CD202b or


    2016-11-16
    Global Markets Direct’s, ‘Angiopoietin 1 Receptor (Endothelial Tyrosine Kinase or Tunica Interna Endothelial Cell Kinase or Tyrosine Kinase With Ig And EGF Homology Domains 2 or Tyrosine Protein Kinase Receptor TEK or Tyrosine Protein Kinase...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0671TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0671TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene...

    Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H2 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0657TDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC0657TDB
  • View Report: Research and Experts Market Report: Huntington Disease - Pipeline Review, H2 2016

    Huntington Disease - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Huntington Disease – Pipeline Review, H2 2016, provides an overview of the Huntington Disease (Central Nervous System) pipeline landscape.

    Huntington's...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8805IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8805IDB
  • View Report: Research and Experts Market Report: Dental Pain - Pipeline Review, H2 2016

    Dental Pain - Pipeline Review, H2 2016


    2016-12-07
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dental Pain - Pipeline Review, H2 2016, provides an overview of the Dental Pain (Central Nervous System) pipeline landscape.

    A pain in the tooth is called dental...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8786IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8786IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H2 2016, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma (also known...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8759IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8759IDB
  • View Report: Research and Experts Market Report: Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose]...

    Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC 2.4.2.30) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC 2.4.2.30) - Pipeline Review, H2 2016’, provides in...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0635TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0635TDB
  • View Report: Research and Experts Market Report: Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2016

    Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Amyotrophic Lateral Sclerosis – Pipeline Review, H2 2016, provides an overview of the Amyotrophic Lateral Sclerosis (Central Nervous System) pipeline landscape.

    Amyo...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8730IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8730IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H2 2016

    Myelodysplastic Syndrome - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome – Pipeline Review, H2 2016, provides an overview of the Myelodysplastic Syndrome (Oncology) pipeline landscape.

    Myelodysplastic syndrome...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8729IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8729IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review, H2 2016, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8721IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8721IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H2 2016

    Small-Cell Lung Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Small-Cell Lung Cancer (Oncology) pipeline landscape.

    Small cell lung cancer...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8706IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8706IDB
  • View Report: Research and Experts Market Report: Dyskinesia Global Clinical Trials Review, H2, 2016

    Dyskinesia Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Dyskinesia Global Clinical Trials Review, H2, 2016" provides an overview of Dyskinesia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyskinesia. Report...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3847CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3847CTIDB
  • View Report: Research and Experts Market Report: Migraine - Pipeline Review, H2 2016

    Migraine - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Migraine – Pipeline Review, H2 2016, provides an overview of the Migraine (Central Nervous System) pipeline landscape.

    Migraine is a disorder characterized...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8702IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8702IDB
  • View Report: Research and Experts Market Report: Lung Transplant Rejection Global Clinical Trials Review, H2, 2016

    Lung Transplant Rejection Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Lung Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview of Lung Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3825CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3825CTIDB
  • View Report: Research and Experts Market Report: Heart Transplant Rejection Global Clinical Trials Review, H2, 2016

    Heart Transplant Rejection Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Heart Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview of Heart Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3822CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3822CTIDB
  • View Report: Research and Experts Market Report: Liver Transplant Rejection Global Clinical Trials Review, H2, 2016

    Liver Transplant Rejection Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Liver Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview of Liver Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3821CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3821CTIDB
  • View Report: Research and Experts Market Report: Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016

    Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview of Kidney Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3820CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3820CTIDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H2 2016

    Schizophrenia - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia – Pipeline Review, H2 2016, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape.

    Schizophrenia is a chronic,...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8727IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8727IDB
  • View Report: Research and Experts Company Reports: Teva Pharmaceutical Industries Limited - Strategy, SWOT and Corporate Finance Report

    Teva Pharmaceutical Industries Limited - Strategy, SWOT and Corporate Finance Report


    2017-08-01
    Teva Pharmaceutical Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and...
  • Company Reports
  • Life Sciences
  • Israel
  • $175.00
  • Report 05IK-B70DDF45-A612-48BC-9095-0F has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-B70DDF45-A612-48BC-9095-0F
  • View Report: Research and Experts Market Report: Parkinson

    Parkinson's Disease Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Parkinson's Disease Global Clinical Trials Review, H2, 2016" provides an overview of Parkinson's Disease clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3778CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3778CTIDB
  • View Report: Research and Experts Market Report: Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2016

    Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Pulmonary Fibrosis – Pipeline Review, H2 2016, provides an overview of the Idiopathic Pulmonary Fibrosis (Respiratory) pipeline landscape.

    Idiopathic...

  • Market Report
  • Respiratory
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8608IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8608IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsed Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Relapsed Acute Myeloid Leukemia (Oncology) pipeline landscape.

    Return...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8605IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8605IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H2 2016

    Asthma - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Asthma – Pipeline Review, H2 2016, provides an overview of the Asthma (Respiratory) pipeline landscape.

    Asthma is a chronic disease involving the airways in...

  • Market Report
  • Respiratory
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8567IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8567IDB
  • View Report: Research and Experts Market Report: Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016

    Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsing Remitting Multiple Sclerosis (RRMS) – Pipeline Review, H2 2016, provides an overview of the Relapsing Remitting Multiple Sclerosis (RRMS) (Central...
  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8533IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8533IDB
  • View Report: Research and Experts Market Report: Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2016

    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H2 2016, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) (Respiratory)...
  • Market Report
  • Respiratory
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8528IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8528IDB
  • View Report: Research and Experts Market Report: Oropharyngeal Candidiasis Global Clinical Trials Review, H2, 2016

    Oropharyngeal Candidiasis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Oropharyngeal Candidiasis Global Clinical Trials Review, H2, 2016" provides an overview of Oropharyngeal Candidiasis clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3774CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3774CTIDB
  • View Report: Research and Experts Market Report: Obstructive Sleep Apnea Global Clinical Trials Review, H2, 2016

    Obstructive Sleep Apnea Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Obstructive Sleep Apnea Global Clinical Trials Review, H2, 2016" provides an overview of Obstructive Sleep Apnea clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3765CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3765CTIDB
  • View Report: Research and Experts Market Report: Perennial Allergic Rhinitis Global Clinical Trials Review, H2, 2016

    Perennial Allergic Rhinitis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Perennial Allergic Rhinitis Global Clinical Trials Review, H2, 2016" provides an overview of Perennial Allergic Rhinitis clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3764CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3764CTIDB
  • View Report: Research and Experts Market Report: Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2016

    Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2016" provides an overview of Left Ventricular Dysfunction clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3751CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3751CTIDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H2 2016

    Psoriasis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H2 2016’, provides an overview of the Psoriasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8494IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8494IDB
  • View Report: Research and Experts Market Report: Opium (Opioid) Addiction - Pipeline Review, H2 2016

    Opium (Opioid) Addiction - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Opium (Opioid) Addiction - Pipeline Review, H2 2016’, provides an overview of the Opium (Opioid) Addiction pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8488IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8488IDB
  • View Report: Research and Experts Market Report: Postherpetic Neuralgia - Pipeline Review, H2 2016

    Postherpetic Neuralgia - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Postherpetic Neuralgia - Pipeline Review, H2 2016’, provides an overview of the Postherpetic Neuralgia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8487IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8487IDB
  • View Report: Research and Experts Market Report: Pulmonary Fibrosis - Pipeline Review, H2 2016

    Pulmonary Fibrosis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H2 2016’, provides an overview of the Pulmonary Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pulmonary...

  • Market Report
  • Respiratory
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8475IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8475IDB
  • View Report: Research and Experts Market Report: External Remote Patient Monitoring Devices - Medical Devices Pipeline Assessment, 2016

    External Remote Patient Monitoring Devices - Medical Devices Pipeline Assessment, 2016


    2016-10-01
    GlobalData's Medical Devices sector report, “External Remote Patient Monitoring Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of External Remote Patient Monitoring Devices currently in pipeline stage.

    The report...

  • Market Report
  • Healthcare
  • Global
  • $4,000.00
  • Report 05IC-GDME0228EPD has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDME0228EPD
  • View Report: Research and Experts Market Report: Chronic Pain - Pipeline Review, H2 2016

    Chronic Pain - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Chronic Pain - Pipeline Review, H2 2016’, provides an overview of the Chronic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Chronic Pain, complete...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8545IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8545IDB
  • View Report: Research and Experts Market Report: Dyskinesia - Pipeline Review, H2 2016

    Dyskinesia - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Dyskinesia - Pipeline Review, H2 2016’, provides an overview of the Dyskinesia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Dyskinesia, complete...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8451IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8451IDB
  • View Report: Research and Experts Market Report: Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016

    Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016


    2016-09-14
    GlobalData's Medical Devices sector report, “Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016" provides an overview of Injectable Drug Delivery currently in pipeline stage.

    The report provides comprehensive information...

  • Market Report
  • Pharmaceuticals
  • Global
  • $4,000.00
  • Report 05IC-GDME0223EPD has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDME0223EPD
  • View Report: Research and Experts Market Report: Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

    Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016


    2016-09-14
    GlobalData's Medical Devices sector report, “Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of Ovarian Cancer Diagnostic Tests currently in pipeline stage.

    The report provides comprehensive...

  • Market Report
  • In Vitro Diagnostics
  • Global
  • $4,000.00
  • Report 05IC-GDME0222EPD has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDME0222EPD
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Current and Future Players

    Multiple Sclerosis - Current and Future Players


    2015-09-10
    GlobalData has released its pharma report, “Multiple Sclerosis - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Multiple Sclerosis Market. The...
  • Market Report
  • Central Nervous System
  • Global
  • $2,995.00
  • Report 05IC-GDHC1057FPR has a star rating of 3.5 out of 5
  • Go to More information on Report 05IC-GDHC1057FPR
  • View Report: Research and Experts Market Report: Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2016

    Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2016’, provides an overview of the Primary Progressive Multiple Sclerosis (PPMS) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8403IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8403IDB
  • View Report: Research and Experts Market Report: Allergic Rhinitis - Current and Future Players

    Allergic Rhinitis - Current and Future Players


    2015-09-01
    GlobalData has released its pharma report, “Allergic Rhinitis - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Allergic Rhinitis Market. The...
  • Market Report
  • Respiratory
  • Global
  • $2,995.00
  • Report 05IC-GDHC1054FPR has a star rating of 3.5 out of 5
  • Go to More information on Report 05IC-GDHC1054FPR
  • View Report: Research and Experts Market Report: Polycythemia Vera - Pipeline Review, H2 2016

    Polycythemia Vera - Pipeline Review, H2 2016


    2016-08-17
    Global Markets Direct’s, ‘Polycythemia Vera - Pipeline Review, H2 2016’, provides an overview of the Polycythemia Vera pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Polycythemia...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8360IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8360IDB
  • View Report: Research and Experts Market Report: Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Pipeline Review, H2 2016

    Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Pipeline Review, H2 2016’, provides in depth analysis on Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0456TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0456TDB
  • View Report: Research and Experts Market Report: Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) - Pipeline Review, H2 2016

    Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0452TDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC0452TDB
  • View Report: Research and Experts Market Report: Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016

    Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016" provides an overview of Ischemic Cardiomyopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Ischemic...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3599CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3599CTIDB
  • View Report: Research and Experts Market Report: Tourette Syndrome Global Clinical Trials Review, H2, 2016

    Tourette Syndrome Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Tourette Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Tourette Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Tourette Syndrome. Report...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3576CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3576CTIDB
  • View Report: Research and Experts Market Report: Sciatic Pain Global Clinical Trials Review, H2, 2016

    Sciatic Pain Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Sciatic Pain Global Clinical Trials Review, H2, 2016" provides an overview of Sciatic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Sciatic Pain. Report includes...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3566CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3566CTIDB
  • View Report: Research and Experts Market Report: Tic Disorder Global Clinical Trials Review, H2, 2016

    Tic Disorder Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Tic Disorder Global Clinical Trials Review, H2, 2016" provides an overview of Tic Disorder clinical trials scenario. This report provides top line data relating to the clinical trials on Tic Disorder. Report includes...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3564CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3564CTIDB
  • View Report: Research and Experts Market Report: Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2016

    Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2016" provides an overview of Relapsing Remitting Multiple Sclerosis (RRMS) clinical trials scenario. This report provides top line data...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3559CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3559CTIDB
  • View Report: Research and Experts Market Report: Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016

    Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016" provides an overview of Relapsing Multiple Sclerosis (RMS) clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3558CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3558CTIDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis Global Clinical Trials Review, H2, 2016

    Multiple Sclerosis Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Multiple Sclerosis Global Clinical Trials Review, H2, 2016" provides an overview of Multiple Sclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Multiple Sclerosis....
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3549CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3549CTIDB
  • View Report: Research and Experts Market Report: Focal Adhesion Kinase (FAK or EC 2.7.10.2) - Pipeline Review, H2 2016

    Focal Adhesion Kinase (FAK or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-07-20
    ‘Focal Adhesion Kinase (FAK or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Focal Adhesion Kinase (FAK or EC 2.7.10.2) targeted pipeline therapeutics.

    The report provides comprehensive information on the Focal Adhesion...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0397TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0397TDB
  • View Report: Research and Experts Market Report: Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2016

    Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2016


    2016-07-20
    ‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2016’, provides an overview of the Anaplastic Large Cell Lymphoma (ALCL) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8288IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8288IDB
  • View Report: Research and Experts Market Report: Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016

    Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016


    2016-07-20
    ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016’, provides an overview of the Non-Alcoholic Steatohepatitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Non-Alcoholic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8327IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8327IDB
  • View Report: Research and Experts Market Report: Tourette Syndrome - Pipeline Review, H2 2016

    Tourette Syndrome - Pipeline Review, H2 2016


    2016-07-20
    ‘Tourette Syndrome - Pipeline Review, H2 2016’, provides an overview of the Tourette Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Tourette Syndrome, complete with analysis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8263IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8263IDB
  • View Report: Research and Experts Company Reports: Akorn, Inc. (AKRX) - Financial and Strategic SWOT Analysis Review

    Akorn, Inc. (AKRX) - Financial and Strategic SWOT Analysis Review


    2016-08-17
    Akorn, Inc. (Akorn) is a generic pharmaceutical company which carries out the development, manufacturing and commercialization of generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal health...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 01B4-GDPH57129FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 01B4-GDPH57129FSA
  • View Report: Research and Experts Company Reports: Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review

    Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review


    2016-08-17
    Biogen Inc (Biogen) is a global biotechnology company that discovers, develops, manufactures and commercializes therapies for treating neurodegenerative diseases, hematologic conditions and autoimmune disorders. The company’s marketed product portfolio...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 01B4-GDPH1307FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 01B4-GDPH1307FSA
  • View Report: Research and Experts Company Reports: Granules India Limited (GRANULES) - Financial and Strategic SWOT Analysis Review

    Granules India Limited (GRANULES) - Financial and Strategic SWOT Analysis Review


    2016-08-09
    Granules India Limited (Granules) is a pharmaceutical manufacturing company, which carries out the research, development and manufacture of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages...
  • Company Reports
  • Life Sciences
  • India
  • $300.00
  • Report 01B4-GDPH82381FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 01B4-GDPH82381FSA
  • View Report: Research and Experts Market Report: Lewy body Dementia Global Clinical Trials Review, H1, 2016

    Lewy body Dementia Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Lewy body Dementia Global Clinical Trials Review, H1, 2016" provides an overview of Lewy body Dementia clinical trials scenario. This report provides top line data relating to the clinical trials on Lewy body Dementia....
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3545CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3545CTIDB
  • View Report: Research and Experts Market Report: Hypersomnia Global Clinical Trials Review, H1, 2016

    Hypersomnia Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Hypersomnia Global Clinical Trials Review, H1, 2016" provides an overview of Hypersomnia clinical trials scenario. This report provides top line data relating to the clinical trials on Hypersomnia. Report includes an...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3525CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3525CTIDB
  • View Report: Research and Experts Project Profile: TEVA - Ulm Pharmaceuticals Plant - Baden-Württemberg - Construction Project Profile

    TEVA - Ulm Pharmaceuticals Plant - Baden-Württemberg - Construction Project Profile


    2016-08-09
    "TEVA – Ulm Pharmaceuticals Plant – Baden-Württemberg - Construction Project Profile" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding,...
  • Project Profile
  • Manufacturing and Construction
  • Germany
  • $75.00
  • Report 00RV-CICPP200956 has a star rating of 3.9 out of 5
  • Go to More information on Report 00RV-CICPP200956
  • View Report: Research and Experts Market Report: Angiopoietin 1 Receptor (Endothelial Tyrosine Kinase or Tunica Interna Endothelial Cell Kinase or Tyrosine Kinase With Ig And EGF...

    Angiopoietin 1 Receptor (Endothelial Tyrosine Kinase or Tunica Interna Endothelial Cell Kinase or Tyrosine Kinase With Ig And EGF Homology Domains 2 or Tyrosine Protein Kinase Receptor TEK or Tyrosine Protein Kinase Receptor TIE 2 or p140 TEK or CD202b or


    2016-06-30
    Global Markets Direct’s, ‘Angiopoietin 1 Receptor (Endothelial Tyrosine Kinase or Tunica Interna Endothelial Cell Kinase or Tyrosine Kinase With Ig And EGF Homology Domains 2 or Tyrosine Protein Kinase Receptor TEK or Tyrosine Protein Kinase...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0227TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0227TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c...

    Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0223TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0223TDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7960IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7960IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2016

    Colorectal Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Colorectal...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7959IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7959IDB
  • View Report: Research and Experts Market Report: HIV / AIDS - Pipeline Review, H1 2016

    HIV / AIDS - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘HIV / AIDS - Pipeline Review, H1 2016’, provides an overview of the HIV / AIDS pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for HIV / AIDS, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7958IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7958IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2016

    Melanoma - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2016’, provides an overview of the Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Melanoma, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7955IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7955IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2016

    Breast Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Breast Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7666IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7666IDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Huntington

    OpportunityAnalyzer: Huntington's Disease - Opportunity Analysis and Forecast to 2024


    2016-05-03
    Huntington’s Disease (HD) is a rare, autosomal-dominant, neurodegenerative disorder, characterized by impaired motor control, cognitive dysfunction, behavioral changes, and mood disorders. Approved treatments for HD across the 7MM are extremely limited,...
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC056POA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC056POA
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H1 2016

    Neuropathic Pain - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Neuropathic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Neuropathic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7966IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7966IDB
  • View Report: Research and Experts Market Report: Parkinson

    Parkinson's Disease - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2016’, provides an overview of the Parkinson's Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7961IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7961IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Non-Small Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7954IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7954IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2016

    Prostate Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Prostate Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Prostate Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7952IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7952IDB
  • View Report: Research and Experts Market Report: Acute Promyelocytic Leukemia Global Clinical Trials Review, H1, 2016

    Acute Promyelocytic Leukemia Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Acute Promyelocytic Leukemia Global Clinical Trials Review, H1, 2016" provides an overview of Acute Promyelocytic Leukemia clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3494CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3494CTIDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3492CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3492CTIDB
  • View Report: Research and Experts Market Report: Apoptosis

    Apoptosis


    2016-04-01
    Over the past few years, availability of apoptosis related products (drugs, kits and reagents) has increased enormously. Global market for apoptosis related products is expected to grow at a high CAGR of about 30% through 2010-2022, and the high growth...
  • Market Report
  • Healthcare
  • Global
  • $3,600.00
  • Report 05HF-MIR008 has a star rating of 4.7 out of 5
  • Go to More information on Report 05HF-MIR008
  • View Report: Research and Experts Market Report: Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT...

    Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT 1 or Poly[ADP-Ribose] Synthase 1 or EC 2.4.2.30) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT 1 or Poly[ADP-Ribose] Synthase 1 or EC 2.4.2.30) - Pipeline Review, H1 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0105TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0105TDB
  • View Report: Research and Experts Market Report: Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2016

    Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2016" provides an overview of Chemotherapy Induced Neutropenia clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3475CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3475CTIDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3473CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3473CTIDB
  • View Report: Research and Experts Market Report: Indolent Lymphoma Global Clinical Trials Review, H1, 2016

    Indolent Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Indolent Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Indolent Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Indolent...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3447CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3447CTIDB
  • View Report: Research and Experts Market Report: Diabetes Insipidus Global Clinical Trials Review, H1, 2016

    Diabetes Insipidus Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Diabetes Insipidus Global Clinical Trials Review, H1, 2016" provides an overview of Diabetes Insipidus clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3439CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3439CTIDB
  • View Report: Research and Experts Market Report: Dyspnea Global Clinical Trials Review, H1, 2016

    Dyspnea Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Dyspnea Global Clinical Trials Review, H1, 2016" provides an overview of Dyspnea clinical trials scenario. This report provides top line data relating to the clinical trials on Dyspnea. Report includes...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3428CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3428CTIDB
  • View Report: Research and Experts Market Report: Bronchitis Global Clinical Trials Review, H1, 2016

    Bronchitis Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Bronchitis Global Clinical Trials Review, H1, 2016" provides an overview of Bronchitis clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchitis. Report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3422CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3422CTIDB
  • View Report: Research and Experts Market Report: Oligodendroglioma Global Clinical Trials Review, H1, 2016

    Oligodendroglioma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Oligodendroglioma Global Clinical Trials Review, H1, 2016" provides an overview of Oligodendroglioma clinical trials scenario. This report provides top line data relating to the clinical trials on Oligodendro...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3419CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3419CTIDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016’, provides an overview of the Multiple Myeloma (Kahler Disease) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8160IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8160IDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Pipeline Review, H1 2016

    Multiple Sclerosis - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2016’, provides an overview of the Multiple Sclerosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Multiple...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7962IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7962IDB
  • View Report: Research and Experts Market Report: Huntington Disease - Pipeline Review, H1 2016

    Huntington Disease - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Huntington Disease - Pipeline Review, H1 2016’, provides an overview of the Huntington Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Huntington...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8162IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8162IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016’, provides an overview of the Kidney Cancer (Renal Cell Cancer) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8161IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8161IDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H1 2016

    Schizophrenia - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H1 2016’, provides an overview of the Schizophrenia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Schizophrenia,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8107IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8107IDB
  • View Report: Research and Experts Market Report: Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2016

    Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2016’, provides an overview of the Amyotrophic Lateral Sclerosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7974IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7974IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Non-Hodgkin...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7970IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7970IDB
  • View Report: Research and Experts Company Reports: Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review

    Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review


    2017-05-09
    Alkermes Plc (Alkermes) is a biopharmaceutical company that focuses on the research, development and commercialization of drugs for the treatment of central nervous system (CNS) diseases. The company’s proprietary products include Aristada, an extended-re...
  • Company Reports
  • Non Specified Industry Company Reports
  • Ireland
  • $125.00
  • Report 05IC-GDPH5650FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH5650FSA
  • View Report: Research and Experts Market Report: Migraine - Pipeline Review, H1 2016

    Migraine - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Migraine - Pipeline Review, H1 2016’, provides an overview of the Migraine pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Migraine, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8006IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8006IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Refractory Acute Myeloid Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8002IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8002IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7997IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7997IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H1 2016

    Small-Cell Lung Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Small-Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7991IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7991IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2016

    Myelodysplastic Syndrome - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2016’, provides an overview of the Myelodysplastic Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7984IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7984IDB
  • View Report: Research and Experts Market Report: Myelofibrosis Global Clinical Trials Review, H1, 2016

    Myelofibrosis Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Myelofibrosis Global Clinical Trials Review, H1, 2016" provides an overview of Myelofibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Myelofibrosis....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3385CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3385CTIDB
  • View Report: Research and Experts Market Report: 5-Hydroxytryptamine Receptor 6 (5-HT-6 or Serotonin Receptor 6 or HTR6) - Pipeline Review, H1 2016

    5-Hydroxytryptamine Receptor 6 (5-HT-6 or Serotonin Receptor 6 or HTR6) - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘5-Hydroxytryptamine Receptor 6 (5-HT-6 or Serotonin Receptor 6 or HTR6) - Pipeline Review, H1 2016’, provides in depth analysis on 5-Hydroxytryptamine Receptor 6 (5-HT-6 or Serotonin Receptor 6 or HTR6) targeted...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0019TDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC0019TDB
  • View Report: Research and Experts Market Report: Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H1 2016

    Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H1 2016’, provides in depth analysis on Calcitonin Gene Related Peptide (CGRP) targeted pipeline therapeutics.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0013TDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC0013TDB
  • View Report: Research and Experts Market Report: Binge Eating Disorder - Pipeline Review, H1 2016

    Binge Eating Disorder - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Binge Eating Disorder - Pipeline Review, H1 2016’, provides an overview of the Binge Eating Disorder pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7928IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7928IDB
  • View Report: Research and Experts Market Report: Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016

    Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Idiopathic Pulmonary Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7818IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7818IDB
  • View Report: Research and Experts Market Report: Head and neck Cancer - Pipeline Review, H1 2016

    Head and neck Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Head...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7685IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7685IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H1 2016

    Asthma - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Asthma - Pipeline Review, H1 2016’, provides an overview of the Asthma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Asthma, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7683IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7683IDB
  • View Report: Research and Experts Market Report: Barretts Esophagus Global Clinical Trials Review, H1, 2016

    Barretts Esophagus Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Barretts Esophagus Global Clinical Trials Review, H1, 2016" provides an overview of Barretts Esophagus clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3365CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3365CTIDB
  • View Report: Research and Experts Market Report: Nasal Polyps Global Clinical Trials Review, H1, 2016

    Nasal Polyps Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Nasal Polyps Global Clinical Trials Review, H1, 2016" provides an overview of Nasal Polyps clinical trials scenario. This report provides top line data relating to the clinical trials on Nasal Polyps....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3359CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3359CTIDB
  • View Report: Research and Experts Market Report: Migraine Global Clinical Trials Review, H1, 2016

    Migraine Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Migraine Global Clinical Trials Review, H1, 2016" provides an overview of Migraine clinical trials scenario. This report provides top line data relating to the clinical trials on Migraine. Report includes...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3353CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3353CTIDB
  • View Report: Research and Experts Market Report: Narcolepsy Global Clinical Trials Review, H1, 2016

    Narcolepsy Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Narcolepsy Global Clinical Trials Review, H1, 2016" provides an overview of Narcolepsy clinical trials scenario. This report provides top line data relating to the clinical trials on Narcolepsy. Report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3352CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3352CTIDB
  • View Report: Research and Experts Market Report: Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2016

    Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2016’, provides an overview of the Relapsing Remitting Multiple Sclerosis (RRMS) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7831IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7831IDB
  • View Report: Research and Experts Market Report: Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016

    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016’, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7688IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7688IDB
  • View Report: Research and Experts Market Report: Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2016

    Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2016


    2016-05-09
    GlobalData's Medical Devices sector report, “Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of Dry Powder Inhaler Devices currently in pipeline stage.

    The report provides comprehensive information...

  • Market Report
  • Medical Devices
  • Global
  • $2,500.00
  • Report 05IC-GDME0183EPD has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDME0183EPD
  • View Report: Research and Experts Market Report: Needle Free Injections - Medical Devices Pipeline Assessment, 2016

    Needle Free Injections - Medical Devices Pipeline Assessment, 2016


    2016-05-01
    GlobalData's Medical Devices sector report, “Needle Free Injections - Medical Devices Pipeline Assessment, 2016" provides an overview of Needle Free Injections currently in pipeline stage.

    The report provides comprehensive information...

  • Market Report
  • Medical Devices
  • Global
  • $2,500.00
  • Report 05IC-GDME0178EPD has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDME0178EPD
  • View Report: Research and Experts Market Report: Postherpetic Neuralgia - Pipeline Review, H1 2016

    Postherpetic Neuralgia - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Postherpetic Neuralgia - Pipeline Review, H1 2016’, provides an overview of the Postherpetic Neuralgia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7853IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7853IDB
  • View Report: Research and Experts Market Report: Pulmonary Fibrosis - Pipeline Review, H1 2016

    Pulmonary Fibrosis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Pulmonary Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pulmonary...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7692IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7692IDB
  • View Report: Research and Experts Market Report: Chronic Pain - Pipeline Review, H1 2016

    Chronic Pain - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Chronic Pain - Pipeline Review, H1 2016’, provides an overview of the Chronic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Chronic Pain, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7690IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7690IDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H1 2016

    Psoriasis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2016’, provides an overview of the Psoriasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7686IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7686IDB
  • View Report: Research and Experts Market Report: Dyskinesia - Pipeline Review, H1 2016

    Dyskinesia - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Dyskinesia - Pipeline Review, H1 2016’, provides an overview of the Dyskinesia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Dyskinesia, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7712IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7712IDB
  • View Report: Research and Experts Market Report: Fatigue Global Clinical Trials Review, H1, 2016

    Fatigue Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Fatigue Global Clinical Trials Review, H1, 2016" provides an overview of Fatigue clinical trials scenario. This report provides top line data relating to the clinical trials on Fatigue. Report includes...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3311CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3311CTIDB
  • View Report: Research and Experts Industry Report: Teva Pharmaceutical Industries, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

    Teva Pharmaceutical Industries, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report


    2016-06-30
    Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive...
  • Industry Report
  • Pharmaceuticals
  • Israel
  • $350.00
  • Report 05IK-C2E9BAF3-51A0-4292-AD7D-13 has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-C2E9BAF3-51A0-4292-AD7D-13
  • View Report: Research and Experts Industry Report: Generics in Scandinavia

    Generics in Scandinavia


    2016-01-04
    Generics in Scandinavia industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including...
  • Industry Report
  • Generic Drugs
  • Scandinavia
  • $350.00
  • Report 05IK-OHME5152 has a star rating of 3.8 out of 5
  • Go to More information on Report 05IK-OHME5152
  • View Report: Research and Experts Industry Report: Generics in North America

    Generics in North America


    2016-01-04
    Generics in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including...
  • Industry Report
  • Generic Drugs
  • North America
  • $350.00
  • Report 05IK-OHME5132 has a star rating of 3.8 out of 5
  • Go to More information on Report 05IK-OHME5132
  • View Report: Research and Experts Industry Report: Generics in Europe

    Generics in Europe


    2016-01-04
    Generics in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key...
  • Industry Report
  • Generic Drugs
  • Europe
  • $350.00
  • Report 05IK-OHME5114 has a star rating of 3.8 out of 5
  • Go to More information on Report 05IK-OHME5114
  • View Report: Research and Experts Industry Report: Generics in Asia-Pacific

    Generics in Asia-Pacific


    2016-01-04
    Generics in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including...
  • Industry Report
  • Generic Drugs
  • Asia Pacific
  • $350.00
  • Report 05IK-OHME5098 has a star rating of 3.7 out of 5
  • Go to More information on Report 05IK-OHME5098
  • View Report: Research and Experts Industry Report: Global Generics

    Global Generics


    2016-01-04
    Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financ...
  • Industry Report
  • Generic Drugs
  • Global
  • $350.00
  • Report 05IK-OHME5077 has a star rating of 3.8 out of 5
  • Go to More information on Report 05IK-OHME5077
  • View Report: Research and Experts Industry Report: Generics in the United Kingdom

    Generics in the United Kingdom


    2016-01-04
    Generics in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players inclu...
  • Industry Report
  • Generic Drugs
  • United Kingdom
  • $350.00
  • Report 05IK-OHME5037 has a star rating of 3.8 out of 5
  • Go to More information on Report 05IK-OHME5037
  • View Report: Research and Experts Industry Report: Generics in Spain

    Generics in Spain


    2016-01-04
    Generics in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key...
  • Industry Report
  • Generic Drugs
  • Spain
  • $350.00
  • Report 05IK-OHME5018 has a star rating of 3.8 out of 5
  • Go to More information on Report 05IK-OHME5018
  • View Report: Research and Experts Industry Report: Generics in the Netherlands

    Generics in the Netherlands


    2016-01-04
    Generics in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players includin...
  • Industry Report
  • Generic Drugs
  • Netherlands
  • $350.00
  • Report 05IK-OHME4997 has a star rating of 3.8 out of 5
  • Go to More information on Report 05IK-OHME4997
  • View Report: Research and Experts Industry Report: Generics in Italy

    Generics in Italy


    2016-01-04
    Generics in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key...
  • Industry Report
  • Generic Drugs
  • Italy
  • $350.00
  • Report 05IK-OHME4983 has a star rating of 3.7 out of 5
  • Go to More information on Report 05IK-OHME4983
  • View Report: Research and Experts Industry Report: Generics in Germany

    Generics in Germany


    2016-01-04
    Generics in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key...
  • Industry Report
  • Generic Drugs
  • Germany
  • $350.00
  • Report 05IK-OHME4959 has a star rating of 3.8 out of 5
  • Go to More information on Report 05IK-OHME4959
  • View Report: Research and Experts Industry Report: Generics in France

    Generics in France


    2016-01-04
    Generics in France industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key...
  • Industry Report
  • Generic Drugs
  • France
  • $350.00
  • Report 05IK-OHME4945 has a star rating of 3.8 out of 5
  • Go to More information on Report 05IK-OHME4945
  • View Report: Research and Experts Industry Report: Generics in Australia

    Generics in Australia


    2016-01-04
    Generics in Australia industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including...
  • Industry Report
  • Generic Drugs
  • Australia
  • $350.00
  • Report 05IK-OHME4895 has a star rating of 3.7 out of 5
  • Go to More information on Report 05IK-OHME4895
  • View Report: Research and Experts Industry Report: Generics in South Korea

    Generics in South Korea


    2016-01-04
    Generics in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including...
  • Industry Report
  • Generic Drugs
  • South Korea
  • $350.00
  • Report 05IK-OHME4870 has a star rating of 3.8 out of 5
  • Go to More information on Report 05IK-OHME4870
  • View Report: Research and Experts Industry Report: Generics in Singapore

    Generics in Singapore


    2016-01-04
    Generics in Singapore industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including...
  • Industry Report
  • Generic Drugs
  • Singapore
  • $350.00
  • Report 05IK-OHME4859 has a star rating of 3.7 out of 5
  • Go to More information on Report 05IK-OHME4859
  • View Report: Research and Experts Industry Report: Generics in Japan

    Generics in Japan


    2016-01-04
    Generics in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key...
  • Industry Report
  • Generic Drugs
  • Japan
  • $350.00
  • Report 05IK-OHME4826 has a star rating of 3.8 out of 5
  • Go to More information on Report 05IK-OHME4826
  • View Report: Research and Experts Industry Report: Generics in China

    Generics in China


    2016-01-04
    Generics in China industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key...
  • Industry Report
  • Generic Drugs
  • China
  • $350.00
  • Report 05IK-OHME4777 has a star rating of 3.7 out of 5
  • Go to More information on Report 05IK-OHME4777
  • View Report: Research and Experts Industry Report: Generics in the United States

    Generics in the United States


    2016-01-04
    Generics in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players includ...
  • Industry Report
  • Generic Drugs
  • United States
  • $350.00
  • Report 05IK-OHME4726 has a star rating of 3.7 out of 5
  • Go to More information on Report 05IK-OHME4726
  • View Report: Research and Experts Industry Report: Generics in Mexico

    Generics in Mexico


    2016-01-04
    Generics in Mexico industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key...
  • Industry Report
  • Generic Drugs
  • Mexico
  • $350.00
  • Report 05IK-OHME4714 has a star rating of 3.8 out of 5
  • Go to More information on Report 05IK-OHME4714
  • View Report: Research and Experts Industry Report: Generics in Canada

    Generics in Canada


    2016-01-04
    Generics in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key...
  • Industry Report
  • Generic Drugs
  • Canada
  • $350.00
  • Report 05IK-OHME4702 has a star rating of 3.7 out of 5
  • Go to More information on Report 05IK-OHME4702
  • View Report: Research and Experts Industry Report: Generics in South Africa

    Generics in South Africa


    2016-01-04
    Generics in South Africa industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including...
  • Industry Report
  • Generic Drugs
  • South Africa
  • $350.00
  • Report 05IK-OHME4690 has a star rating of 3.8 out of 5
  • Go to More information on Report 05IK-OHME4690
  • View Report: Research and Experts Market Report: Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H1 2016

    Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H1 2016’, provides an overview of the Primary Progressive Multiple Sclerosis (PPMS) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7763IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7763IDB
  • View Report: Research and Experts Market Report: Huntington Disease Global Clinical Trials Review, H1, 2016

    Huntington Disease Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Huntington Disease Global Clinical Trials Review, H1, 2016" provides an overview of Huntington Disease clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3303CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3303CTIDB
  • View Report: Research and Experts Market Report: Tardive Dyskinesia Global Clinical Trials Review, H1, 2016

    Tardive Dyskinesia Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Tardive Dyskinesia Global Clinical Trials Review, H1, 2016" provides an overview of Tardive Dyskinesia clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3301CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3301CTIDB
  • View Report: Research and Experts Market Report: Cancer Pain Global Clinical Trials Review, H1, 2016

    Cancer Pain Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Cancer Pain Global Clinical Trials Review, H1, 2016" provides an overview of Cancer Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer Pain. Report...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3297CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3297CTIDB
  • View Report: Research and Experts Market Report: Traumatic Brain Injury Global Clinical Trials Review, H1, 2016

    Traumatic Brain Injury Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Traumatic Brain Injury Global Clinical Trials Review, H1, 2016" provides an overview of Traumatic Brain Injury clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3295CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3295CTIDB
  • View Report: Research and Experts Market Report: Cluster Headache Syndrome Global Clinical Trials Review, H1, 2016

    Cluster Headache Syndrome Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Cluster Headache Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Cluster Headache Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3294CTIDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IC-GDHC3294CTIDB
  • View Report: Research and Experts Market Report: Dyskinesia Global Clinical Trials Review, H1, 2016

    Dyskinesia Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Dyskinesia Global Clinical Trials Review, H1, 2016" provides an overview of Dyskinesia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyskinesia. Report...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3291CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3291CTIDB
  • View Report: Research and Experts Market Report: Asthma Global Clinical Trials Review, H1, 2016

    Asthma Global Clinical Trials Review, H1, 2016


    2016-03-11
    GlobalData's clinical trial report, “Asthma Global Clinical Trials Review, H1, 2016" provides an overview of Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Asthma. Report includes...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3281CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3281CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Hodgkin

    OpportunityAnalyzer: Hodgkin's Lymphoma (HL) - Opportunity Analysis and Forecasts to 2024


    2016-01-01
    Hodgkin’s lymphoma (HL), or Hodgkin’s disease, is a malignancy which involves the lymph nodes and the lymphatic system. HL is a relatively rare type of cancer, accounting for 12% of all lymphomas and 0.6% of all new cancer cases, but overall...
  • Market Report
  • Construction Materials
  • Global
  • $10,995.00
  • Report 05IC-GDHC052POA has a star rating of 3.8 out of 5
  • Go to More information on Report 05IC-GDHC052POA
  • View Report: Research and Experts Market Report: Sleep Apnea Global Clinical Trials Review, H1, 2016

    Sleep Apnea Global Clinical Trials Review, H1, 2016


    2016-02-29
    GlobalData's clinical trial report, “Sleep Apnea Global Clinical Trials Review, H1, 2016" provides an overview of Sleep Apnea clinical trials scenario. This report provides top line data relating to the clinical trials on Sleep Apnea. Report...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3248CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3248CTIDB
  • View Report: Research and Experts Company Reports: Allergan Plc (AGN) - Medical Equipment - Deals and Alliances Profile

    Allergan Plc (AGN) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Allergan Plc (Allergan), formerly Actavis is a specialty pharmaceutical company, which focuses on the development, manufacturing, marketing and distribution of specialty branded, generic, bio-similar, branded generics and over-the-counter (OTC) products....
  • Company Reports
  • Medical Devices
  • Ireland
  • $250.00
  • Report 05IB-GDME4874D has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GDME4874D
  • View Report: Research and Experts Company Reports: Amgen Inc. (AMGN) - Medical Equipment - Deals and Alliances Profile

    Amgen Inc. (AMGN) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Amgen Inc. (Amgen) is a biotechnology company. It undertakes the discovery, development, manufacture and commercialization of innovative human therapeutics. The company pioneered the development of new products based on advances in recombinant DNA and...
  • Company Reports
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME3778D has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GDME3778D
  • View Report: Research and Experts Company Reports: Mylan N.V. (MYL) - Medical Equipment - Deals and Alliances Profile

    Mylan N.V. (MYL) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Mylan N.V., formerly, Mylan Inc. is one of the leading generic drug and specialty drug manufacturing companies in the world. The company focuses on the development, licensing, production, commercialization and distribution of generics, branded generics,...
  • Company Reports
  • Medical Devices
  • United Kingdom
  • $250.00
  • Report 05IB-GDME31565D has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GDME31565D
  • View Report: Research and Experts Company Reports: Biogen, Inc. (BIIB) - Medical Equipment - Deals and Alliances Profile

    Biogen, Inc. (BIIB) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Biogen, Inc. (Biogen) is a global biotechnology company that discovers, develops, manufactures and commercializes therapies for treating neurodegenerative diseases, hematologic conditions and autoimmune disorders. The company’s marketed product portfolio...
  • Company Reports
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME1307D has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GDME1307D
  • View Report: Research and Experts Company Reports: Dexcel Pharma - Strategic SWOT Analysis Review

    Dexcel Pharma - Strategic SWOT Analysis Review


    2016-03-01
    Dexcel Pharma (Dexcel) is a pharmaceutical company which develops and markets healthcare products. Its products include Cetirizine, Zyllergy, Alvoran, Betaren, Defanac, Diclofenac, Diclofenac Atid, Aceridex, Aspirin, Cadex, Losartan, Metoprolol Atid,...
  • Company Reports
  • Construction Materials
  • Israel
  • $125.00
  • Report 05IB-GDPH141685SA has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GDPH141685SA
  • View Report: Research and Experts Market Report: Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2016

    Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2016’, provides an overview of the Anaplastic Large Cell Lymphoma (ALCL) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7664IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7664IDB
  • View Report: Research and Experts Market Report: Tourette Syndrome - Pipeline Review, H1 2016

    Tourette Syndrome - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Tourette Syndrome - Pipeline Review, H1 2016’, provides an overview of the Tourette Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Tourette...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7582IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7582IDB
  • View Report: Research and Experts Market Report: Fatigue - Pipeline Review, H1 2016

    Fatigue - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Fatigue - Pipeline Review, H1 2016’, provides an overview of the Fatigue pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Fatigue, complete with analysis...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7568IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC7568IDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Systemic Sclerosis (Scleroderma) - Opportunity Analysis and Forecast to 2024

    OpportunityAnalyzer: Systemic Sclerosis (Scleroderma) - Opportunity Analysis and Forecast to 2024


    2015-12-10
    Systemic sclerosis (SSc) is a complex autoimmune disease that affects the skin and multiple internal organs. Common manifestations of SSc that are included in this report are skin fibrosis, lung fibrosis, and digital vasculopathy (including Raynaud’s...
  • Market Report
  • Construction Materials
  • Global
  • $10,995.00
  • Report 05IC-GDHC044POA has a star rating of 3.6 out of 5
  • Go to More information on Report 05IC-GDHC044POA
  • View Report: Research and Experts Market Report: Hemostasis Global Clinical Trials Review, H1, 2016

    Hemostasis Global Clinical Trials Review, H1, 2016


    2016-01-31
    GlobalData's clinical trial report, “Hemostasis Global Clinical Trials Review, H1, 2016" provides an overview of Hemostasis clinical trials scenario. This report provides top line data relating to the clinical trials on Hemostasis. Report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3209CTIDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IC-GDHC3209CTIDB
  • View Report: Research and Experts Market Report: Filariasis Global Clinical Trials Review, H1, 2016

    Filariasis Global Clinical Trials Review, H1, 2016


    2016-01-20
    GlobalData's clinical trial report, “Filariasis Global Clinical Trials Review, H1, 2016" provides an overview of Filariasis clinical trials scenario. This report provides top line data relating to the clinical trials on Filariasis. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3195CTIDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IC-GDHC3195CTIDB
  • View Report: Research and Experts Market Report: Postherpetic Neuralgia - Pipeline Review, H2 2015

    Postherpetic Neuralgia - Pipeline Review, H2 2015


    2015-10-30
    Postherpetic Neuralgia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Postherpetic Neuralgia - Pipeline Review, H2 2015’, provides an overview of the Postherpetic Neuralgia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7240IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC7240IDB
  • View Report: Research and Experts Market Report: Drug Addiction - Pipeline Review, H2 2015

    Drug Addiction - Pipeline Review, H2 2015


    2015-10-28
    Drug Addiction - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Drug Addiction - Pipeline Review, H2 2015’, provides an overview of the Drug Addiction’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7225IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC7225IDB
  • View Report: Research and Experts Market Report: Growth Hormone Deficiency - Pipeline Review, H2 2015

    Growth Hormone Deficiency - Pipeline Review, H2 2015


    2015-10-14
    Growth Hormone Deficiency - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Growth Hormone Deficiency - Pipeline Review, H2 2015’, provides an overview of the Growth Hormone Deficiency’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6857IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6857IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H2 2015

    Cognitive Impairment - Pipeline Review, H2 2015


    2015-09-30
    Cognitive Impairment - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2015’, provides an overview of the Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7070IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC7070IDB
  • View Report: Research and Experts Market Report: Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2015

    Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2015


    2015-09-30
    Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2015’, provides an overview of the Primary Progressive Multiple...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7179IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC7179IDB
  • View Report: Research and Experts Market Report: Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2015

    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2015


    2015-09-30
    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2015’, provides an overview of the Metastatic Adenocarcinoma of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6979IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6979IDB
  • View Report: Research and Experts Market Report: Moderate Pain - Pipeline Review, H2 2015

    Moderate Pain - Pipeline Review, H2 2015


    2015-09-30
    Moderate Pain - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Moderate Pain - Pipeline Review, H2 2015’, provides an overview of the Moderate Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6976IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6976IDB
  • View Report: Research and Experts Market Report: Dyskinesia - Pipeline Review, H2 2015

    Dyskinesia - Pipeline Review, H2 2015


    2015-09-23
    Dyskinesia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Dyskinesia - Pipeline Review, H2 2015’, provides an overview of the Dyskinesia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7085IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC7085IDB
  • View Report: Research and Experts Market Report: Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015

    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015


    2015-09-16
    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015’, provides an overview of the Transitional Cell...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7098IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC7098IDB
  • View Report: Research and Experts Market Report: Tourette Syndrome - Pipeline Review, H2 2015

    Tourette Syndrome - Pipeline Review, H2 2015


    2015-08-26
    Tourette Syndrome - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Tourette Syndrome - Pipeline Review, H2 2015’, provides an overview of the Tourette Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7011IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC7011IDB
  • View Report: Research and Experts Market Report: Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2015

    Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2015


    2015-08-26
    Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2015’, provides an overview of the Anaplastic Large Cell Lymphoma (ALCL)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7002IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC7002IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015


    2015-08-19
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7054IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC7054IDB
  • View Report: Research and Experts Market Report: Tardive Dyskinesia - Pipeline Review, H2 2015

    Tardive Dyskinesia - Pipeline Review, H2 2015


    2015-07-22
    Tardive Dyskinesia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Tardive Dyskinesia - Pipeline Review, H2 2015’, provides an overview of the Tardive Dyskinesia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6918IDB has a star rating of 3.2 out of 5
  • Go to More information on Report 05IB-GMDHC6918IDB
  • View Report: Research and Experts Market Report: Fatigue - Pipeline Review, H2 2015

    Fatigue - Pipeline Review, H2 2015


    2015-07-22
    Fatigue - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Fatigue - Pipeline Review, H2 2015’, provides an overview of the Fatigue’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6911IDB has a star rating of 3.1 out of 5
  • Go to More information on Report 05IB-GMDHC6911IDB
  • View Report: Research and Experts Market Report: Acute Coronary Syndrome - Pipeline Review, H2 2015

    Acute Coronary Syndrome - Pipeline Review, H2 2015


    2015-07-15
    Acute Coronary Syndrome - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Acute Coronary Syndrome - Pipeline Review, H2 2015’, provides an overview of the Acute Coronary Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6819IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6819IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2015

    Pancreatic Cancer - Pipeline Review, H1 2015


    2015-06-30
    Pancreatic Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6674IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6674IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler

    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015


    2015-06-30
    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015’, provides an overview of the Multiple Myeloma (Kahler's Disease)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6505IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6505IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2015

    Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6504IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6504IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2015

    Melanoma - Pipeline Review, H1 2015


    2015-06-30
    Melanoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2015’, provides an overview of the Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6503IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6503IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2015

    Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6502IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6502IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-06-30
    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6498IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6498IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-30
    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Non-Small Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6495IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6495IDB
  • View Report: Research and Experts Market Report: Parkinson

    Parkinson's Disease - Pipeline Review, H1 2015


    2015-06-30
    Parkinson's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2015’, provides an overview of the Parkinson's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6562IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6562IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2015

    Rheumatoid Arthritis - Pipeline Review, H1 2015


    2015-06-30
    Rheumatoid Arthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6561IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6561IDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Pipeline Review, H1 2015

    Multiple Sclerosis - Pipeline Review, H1 2015


    2015-06-30
    Multiple Sclerosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2015’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6497IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6497IDB
  • View Report: Research and Experts Market Report: HIV / AIDS - Pipeline Review, H1 2015

    HIV / AIDS - Pipeline Review, H1 2015


    2015-06-30
    HIV / AIDS - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘HIV / AIDS - Pipeline Review, H1 2015’, provides an overview of the HIV / AIDS’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6496IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6496IDB
  • View Report: Research and Experts Market Report: Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Inflammatory Bowel Disease - Pipeline Review, H1 2015


    2015-06-30
    Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Inflammatory Bowel Disease - Pipeline Review, H1 2015’, provides an overview of the Inflammatory Bowel Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6494IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6494IDB
  • View Report: Research and Experts Market Report: Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015

    Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015


    2015-06-30
    Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015’, provides an overview of the Transitional...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6814IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6814IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease - Pipeline Review, H1 2015


    2015-06-30
    Crohn's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Crohn's Disease - Pipeline Review, H1 2015’, provides an overview of the Crohn's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6569IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6569IDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H1 2015

    Schizophrenia - Pipeline Review, H1 2015


    2015-06-30
    Schizophrenia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H1 2015’, provides an overview of the Schizophrenia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6568IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6568IDB
  • View Report: Research and Experts Market Report: Hypertension - Pipeline Review, H1 2015

    Hypertension - Pipeline Review, H1 2015


    2015-06-30
    Hypertension - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hypertension - Pipeline Review, H1 2015’, provides an overview of the Hypertension’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6565IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6565IDB
  • View Report: Research and Experts Market Report: Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2015

    Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2015


    2015-06-30
    Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2015’, provides an overview of the Amyotrophic Lateral Sclerosis’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6508IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6508IDB
  • View Report: Research and Experts Market Report: Kidney Cancer - Pipeline Review, H1 2015

    Kidney Cancer - Pipeline Review, H1 2015


    2015-06-30
    Kidney Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Kidney Cancer - Pipeline Review, H1 2015’, provides an overview of the Kidney Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6492IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6492IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H1 2015

    Neuropathic Pain - Pipeline Review, H1 2015


    2015-06-30
    Neuropathic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2015’, provides an overview of the Neuropathic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6491IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6491IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6490IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6490IDB
  • View Report: Research and Experts Market Report: Colon Cancer - Pipeline Review, H1 2015

    Colon Cancer - Pipeline Review, H1 2015


    2015-06-30
    Colon Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2015’, provides an overview of the Colon Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6678IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6678IDB
  • View Report: Research and Experts Market Report: Neuroblastoma - Pipeline Review, H1 2015

    Neuroblastoma - Pipeline Review, H1 2015


    2015-06-30
    Neuroblastoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Neuroblastoma - Pipeline Review, H1 2015’, provides an overview of the Neuroblastoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6575IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6575IDB
  • View Report: Research and Experts Market Report: Huntington

    Huntington's Disease - Pipeline Review, H1 2015


    2015-06-30
    Huntington's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Huntington's Disease - Pipeline Review, H1 2015’, provides an overview of the Huntington's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6512IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6512IDB
  • View Report: Research and Experts Market Report: Migraine - Pipeline Review, H1 2015

    Migraine - Pipeline Review, H1 2015


    2015-06-24
    Migraine - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Migraine - Pipeline Review, H1 2015’, provides an overview of the Migraine’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6692IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6692IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Myelodysplastic Syndrome - Pipeline Review, H1 2015


    2015-06-24
    Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2015’, provides an overview of the Myelodysplastic Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6685IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6685IDB
  • View Report: Research and Experts Market Report: Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015

    Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015


    2015-06-10
    Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015’, provides an overview of the Bipolar Disorder (Manic Depression)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6704IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6704IDB
  • View Report: Research and Experts Market Report: Neutropenia - Pipeline Review, H1 2015

    Neutropenia - Pipeline Review, H1 2015


    2015-05-29
    Neutropenia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Neutropenia - Pipeline Review, H1 2015’, provides an overview of the Neutropenia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6596IDB has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-GMDHC6596IDB
  • View Report: Research and Experts Market Report: Contraception - Pipeline Review, H1 2015

    Contraception - Pipeline Review, H1 2015


    2015-05-29
    Contraception - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Contraception - Pipeline Review, H1 2015’, provides an overview of the Contraception’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6592IDB has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-GMDHC6592IDB
  • View Report: Research and Experts Market Report: Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015

    Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015


    2015-05-29
    Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015’, provides an overview of the Relapsing Remitting Multiple...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6590IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6590IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H1 2015

    Osteoarthritis Pain - Pipeline Review, H1 2015


    2015-05-29
    Osteoarthritis Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H1 2015’, provides an overview of the Osteoarthritis Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6526IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6526IDB
  • View Report: Research and Experts Market Report: Binge Eating Disorder - Pipeline Review, H1 2015

    Binge Eating Disorder - Pipeline Review, H1 2015


    2015-05-13
    Binge Eating Disorder - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Binge Eating Disorder - Pipeline Review, H1 2015’, provides an overview of the Binge Eating Disorder’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6771IDB has a star rating of 2.9 out of 5
  • Go to More information on Report 05IB-GMDHC6771IDB
  • View Report: Research and Experts Market Report: Lupus Nephritis - Pipeline Review, H1 2015

    Lupus Nephritis - Pipeline Review, H1 2015


    2015-04-30
    Lupus Nephritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Lupus Nephritis - Pipeline Review, H1 2015’, provides an overview of the Lupus Nephritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6550IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6550IDB
  • View Report: Research and Experts Market Report: Postherpetic Neuralgia - Pipeline Review, H1 2015

    Postherpetic Neuralgia - Pipeline Review, H1 2015


    2015-04-30
    Postherpetic Neuralgia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Postherpetic Neuralgia - Pipeline Review, H1 2015’, provides an overview of the Postherpetic Neuralgia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6546IDB has a star rating of 3.2 out of 5
  • Go to More information on Report 05IB-GMDHC6546IDB
  • View Report: Research and Experts Market Report: Eosinophilic Esophagitis - Pipeline Review, H1 2015

    Eosinophilic Esophagitis - Pipeline Review, H1 2015


    2015-04-29
    Eosinophilic Esophagitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Eosinophilic Esophagitis - Pipeline Review, H1 2015’, provides an overview of the Eosinophilic Esophagitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6633IDB has a star rating of 2.9 out of 5
  • Go to More information on Report 05IB-GMDHC6633IDB
  • View Report: Research and Experts Market Report: Febrile Neutropenia - Pipeline Review, H1 2015

    Febrile Neutropenia - Pipeline Review, H1 2015


    2015-04-29
    Febrile Neutropenia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Febrile Neutropenia - Pipeline Review, H1 2015’, provides an overview of the Febrile Neutropenia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6629IDB has a star rating of 2.9 out of 5
  • Go to More information on Report 05IB-GMDHC6629IDB
  • View Report: Research and Experts Market Report: Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2015

    Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2015


    2015-04-22
    Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2015’, provides an overview of the Relapsing Multiple Sclerosis (RMS)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6636IDB has a star rating of 2.9 out of 5
  • Go to More information on Report 05IB-GMDHC6636IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H1 2015

    Cognitive Impairment - Pipeline Review, H1 2015


    2015-03-31
    Cognitive Impairment - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H1 2015’, provides an overview of the Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6243IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6243IDB
  • View Report: Research and Experts Market Report: Addiction - Pipeline Review, H1 2015

    Addiction - Pipeline Review, H1 2015


    2015-03-31
    Addiction - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Addiction - Pipeline Review, H1 2015’, provides an overview of the Addiction’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6241IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6241IDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H1 2015

    Psoriasis - Pipeline Review, H1 2015


    2015-03-26
    Psoriasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Psoriasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6361IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6361IDB
  • View Report: Research and Experts Market Report: Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H1 2015

    Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H1 2015


    2015-03-19
    Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H1 2015’, provides an overview of the Primary Progressive Multiple...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6441IDB has a star rating of 3.0 out of 5
  • Go to More information on Report 05IB-GMDHC6441IDB
  • View Report: Research and Experts Market Report: Raynauds Disease - Pipeline Review, H1 2015

    Raynauds Disease - Pipeline Review, H1 2015


    2015-03-19
    Raynauds Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Raynauds Disease - Pipeline Review, H1 2015’, provides an overview of the Raynauds Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6430IDB has a star rating of 3.0 out of 5
  • Go to More information on Report 05IB-GMDHC6430IDB
  • View Report: Research and Experts Market Report: Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015

    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015


    2015-02-24
    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015’, provides an overview of the Transitional Cell...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6271IDB has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-GMDHC6271IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-02-18
    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6127IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6127IDB
  • View Report: Research and Experts Market Report: Chronic Pain - Pipeline Review, H1 2015

    Chronic Pain - Pipeline Review, H1 2015


    2015-02-10
    Chronic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Pain - Pipeline Review, H1 2015’, provides an overview of the Chronic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6129IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6129IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2015

    Type 2 Diabetes - Pipeline Review, H1 2015


    2015-02-10
    Type 2 Diabetes - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2015’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6121IDB has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-GMDHC6121IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H1 2015

    Mantle Cell Lymphoma - Pipeline Review, H1 2015


    2015-01-30
    Mantle Cell Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6139IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6139IDB
  • View Report: Research and Experts Market Report: Women Infertility - Pipeline Review, H1 2015

    Women Infertility - Pipeline Review, H1 2015


    2015-01-30
    Women Infertility - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Women Infertility - Pipeline Review, H1 2015’, provides an overview of the Women Infertility’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6133IDB has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-GMDHC6133IDB
  • View Report: Research and Experts Market Report: Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015

    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015


    2015-01-30
    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015’, provides an overview of the Chronic Obstructive Pulmonary...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6009IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6009IDB
  • View Report: Research and Experts Market Report: Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015

    Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015


    2015-01-30
    Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015’, provides an overview of the Anaplastic Large Cell Lymphoma (ALCL)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6180IDB has a star rating of 3.0 out of 5
  • Go to More information on Report 05IB-GMDHC6180IDB
  • View Report: Research and Experts Market Report: Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015

    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015


    2015-01-30
    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015’, provides an overview of the Metastatic Adenocarcinoma of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6158IDB has a star rating of 3.2 out of 5
  • Go to More information on Report 05IB-GMDHC6158IDB
  • View Report: Research and Experts Market Report: Depression - Pipeline Review, H1 2015

    Depression - Pipeline Review, H1 2015


    2015-01-30
    Depression - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Depression - Pipeline Review, H1 2015’, provides an overview of the Depression’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6011IDB has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-GMDHC6011IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer - Pipeline Review, H1 2015

    Head And Neck Cancer - Pipeline Review, H1 2015


    2015-01-30
    Head And Neck Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6010IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6010IDB
  • View Report: Research and Experts Market Report: Fatigue - Pipeline Review, H1 2015

    Fatigue - Pipeline Review, H1 2015


    2015-01-22
    Fatigue - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Fatigue - Pipeline Review, H1 2015’, provides an overview of the Fatigue’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6097IDB has a star rating of 2.7 out of 5
  • Go to More information on Report 05IB-GMDHC6097IDB
  • View Report: Research and Experts Market Report: Constipation - Pipeline Review, H1 2015

    Constipation - Pipeline Review, H1 2015


    2015-01-22
    Constipation - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Constipation - Pipeline Review, H1 2015’, provides an overview of the Constipation’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6050IDB has a star rating of 3.1 out of 5
  • Go to More information on Report 05IB-GMDHC6050IDB
  • View Report: Research and Experts Market Report: Growth Hormone Deficiency - Pipeline Review, H1 2015

    Growth Hormone Deficiency - Pipeline Review, H1 2015


    2015-01-22
    Growth Hormone Deficiency - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Growth Hormone Deficiency - Pipeline Review, H1 2015’, provides an overview of the Growth Hormone Deficiency’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6043IDB has a star rating of 3.1 out of 5
  • Go to More information on Report 05IB-GMDHC6043IDB
  • View Report: Research and Experts Market Report: Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015

    Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015


    2015-01-22
    Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015’, provides an overview of the Chemotherapy Induced Neutropenia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6036IDB has a star rating of 3.1 out of 5
  • Go to More information on Report 05IB-GMDHC6036IDB
  • View Report: Research and Experts Market Report: Autism - Pipeline Review, H1 2015

    Autism - Pipeline Review, H1 2015


    2015-01-22
    Autism - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Autism - Pipeline Review, H1 2015’, provides an overview of the Autism’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6033IDB has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-GMDHC6033IDB
  • View Report: Research and Experts Market Report: Metastatic Pancreatic Cancer - Pipeline Review, H1 2015

    Metastatic Pancreatic Cancer - Pipeline Review, H1 2015


    2015-01-22
    Metastatic Pancreatic Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Pancreatic Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6022IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6022IDB
  • View Report: Research and Experts Market Report: Glaucoma - Pipeline Review, H1 2015

    Glaucoma - Pipeline Review, H1 2015


    2015-01-22
    Glaucoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Glaucoma - Pipeline Review, H1 2015’, provides an overview of the Glaucoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6016IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6016IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H1 2015

    Asthma - Pipeline Review, H1 2015


    2015-01-22
    Asthma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Asthma - Pipeline Review, H1 2015’, provides an overview of the Asthma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6007IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6007IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2015

    Breast Cancer - Pipeline Review, H1 2015


    2015-01-22
    Breast Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6006IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6006IDB
  • View Report: Research and Experts Company Reports: Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review

    Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review


    2017-03-01
    Biogen Inc (Biogen) is a global biotechnology company that manufactures and markets drugs for the treatment of neurodegenerative diseases and rare and autoimmune disorders. Its marketed products include Avonex (interferon beta-1a), Tysabri (natalizumab),...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH1307FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH1307FSA
  • View Report: Research and Experts Company Reports: Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review

    Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review


    2016-08-02
    Jubilant Life Sciences Limited (Jubilant) is an integrated pharmaceutical and life sciences company that carries out the manufacture and supply of radiopharmaceuticals, allergy therapy products, active pharmaceutical ingredients (APIs), solid dosage formu...
  • Company Reports
  • Life Sciences
  • India
  • $125.00
  • Report 05IC-GDPH22222FSA has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDPH22222FSA
  • View Report: Research and Experts Company Reports: Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review

    Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review


    2017-08-30
    Granules India Ltd (Granules) is a pharmaceutical manufacturing company, which carries out the research, development and manufacture of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs)....
  • Company Reports
  • Life Sciences
  • India
  • $125.00
  • Report 05IC-GDPH82381FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH82381FSA
  • View Report: Research and Experts Company Reports: Hikma Pharmaceuticals Plc (HIK) - Financial and Strategic SWOT Analysis Review

    Hikma Pharmaceuticals Plc (HIK) - Financial and Strategic SWOT Analysis Review


    2017-06-06
    Hikma Pharmaceuticals Plc (Hikma) is a pharmaceutical company which undertakes the development, manufacturing and marketing of branded and non-branded generics and in-licensed products. The company specializes in the therapeutic areas of cardiovascular...
  • Company Reports
  • Life Sciences
  • United Kingdom
  • $125.00
  • Report 05IC-GDPH57970FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH57970FSA
  • View Report: Research and Experts Company Reports: Tesaro Inc (TSRO) - Financial and Strategic SWOT Analysis Review

    Tesaro Inc (TSRO) - Financial and Strategic SWOT Analysis Review


    2017-04-11
    Tesaro Inc (Tesaro) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates, comprising rolapitant, niraparib, and the product candidates under its immuno-oncology platform. VARUBI,...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH281619FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH281619FSA
  • View Report: Research and Experts Company Reports: Fresenius Kabi AG - Strategic SWOT Analysis Review

    Fresenius Kabi AG - Strategic SWOT Analysis Review


    2017-07-05
    Fresenius Kabi AG (Fresenius Kabi), a subsidiary of Fresenius SE & Co KGaA, develops, manufactures and markets pharmaceuticals and medical devices. The company's integrated product portfolio includes intravenously administered drugs, infusion...
  • Company Reports
  • Medical Devices
  • Germany
  • $125.00
  • Report 05IC-GDME6226SA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDME6226SA
  • View Report: Research and Experts Company Reports: Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review

    Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review


    2017-04-26
    Acorda Therapeutics Inc (Acorda) is a biopharmaceutical company that discovers, develops, and commercializes therapies for treating patients with neurological disorders. The company’s commercial products include Ampyra (dalfampridine), a treatment...
  • Company Reports
  • Non Specified Industry Company Reports
  • United States
  • $125.00
  • Report 05IC-GDPH27012FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH27012FSA
  • View Report: Research and Experts Company Reports: Taro Pharmaceutical Industries Ltd (TARO) - Financial and Strategic SWOT Analysis Review

    Taro Pharmaceutical Industries Ltd (TARO) - Financial and Strategic SWOT Analysis Review


    2017-08-08
    Taro Pharmaceutical Industries Ltd (Taro), a subsidiary of Sun Pharmaceutical Industries Ltd, research develops and markets healthcare products. The company manufactures prescription drugs, nonprescription drugs and active pharmaceutical ingredients (APIs...
  • Company Reports
  • Life Sciences
  • Israel
  • $125.00
  • Report 05IC-GDPH33398FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH33398FSA
  • View Report: Research and Experts Company Reports: Insys Therapeutics Inc (INSY) - Financial and Strategic SWOT Analysis Review

    Insys Therapeutics Inc (INSY) - Financial and Strategic SWOT Analysis Review


    2017-04-26
    Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems to improve the quality of life for patients. The company has one marketed product, namely, Subsys, a sublingual...
  • Company Reports
  • Non Specified Industry Company Reports
  • United States
  • $125.00
  • Report 05IC-GDPH123460FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH123460FSA
  • View Report: Research and Experts Company Reports: Pharmstandard (PHST) - Financial and Strategic SWOT Analysis Review

    Pharmstandard (PHST) - Financial and Strategic SWOT Analysis Review


    2017-08-30
    Pharmstandard develops, manufactures and distributes pharmaceutical products. The company offers prescription pharmaceuticals and over-the drug (OTC) pharmaceuticals. It also provides active pharmaceutical ingredients and contract manufacturing services....
  • Company Reports
  • Life Sciences
  • Russian Federation
  • $125.00
  • Report 05IC-GDPH82561FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH82561FSA
  • View Report: Research and Experts Company Reports: Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review

    Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review


    2017-06-13
    Antares Pharma Inc (Antares Pharma) is a specialty pharmaceutical company that focuses on development and commercialization of self-injection pharmaceutical drugs and technologies and topical gel-based products. The company has product OTREXUP which is...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH3783FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH3783FSA
  • View Report: Research and Experts Company Reports: Akorn Inc (AKRX) - Financial and Strategic SWOT Analysis Review

    Akorn Inc (AKRX) - Financial and Strategic SWOT Analysis Review


    2017-03-28
    Akorn Inc (Akorn) is a pharmaceutical company which carries out the development, manufacturing and commercialization of generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal health pharmaceut...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH57129FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH57129FSA
  • View Report: Research and Experts Company Reports: Allergan Plc (AGN) - Financial and Strategic SWOT Analysis Review

    Allergan Plc (AGN) - Financial and Strategic SWOT Analysis Review


    2017-03-15
    Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology,...
  • Company Reports
  • Life Sciences
  • Ireland
  • $125.00
  • Report 05IC-GDPH4874FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH4874FSA
  • View Report: Research and Experts Company Reports: Mylan NV (MYL) - Financial and Strategic SWOT Analysis Review

    Mylan NV (MYL) - Financial and Strategic SWOT Analysis Review


    2017-03-21
    Mylan NV (Mylan) is a pharmaceutical company, which focuses on development, licensing, manufacture, marketing and distribution of generics, branded medicines and consumer healthcare products. It offers pharmaceutical products in multiple forms across...
  • Company Reports
  • Life Sciences
  • United Kingdom
  • $125.00
  • Report 05IC-GDPH31565FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH31565FSA
  • View Report: Research and Experts Company Reports: Impax Laboratories Inc (IPXL) - Financial and Strategic SWOT Analysis Review

    Impax Laboratories Inc (IPXL) - Financial and Strategic SWOT Analysis Review


    2017-05-02
    Impax Laboratories Inc (Impax) is a pharmaceutical company develops, manufacture and market generic and branded pharmaceuticals by applying its formulation expertise and drug delivery technology. The company operates develops and markets proprietary brand...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH35542FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH35542FSA
  • View Report: Research and Experts Company Reports: Genmab AS (GEN) - Financial and Strategic SWOT Analysis Review

    Genmab AS (GEN) - Financial and Strategic SWOT Analysis Review


    2017-07-12
    Genmab A/S (Genmab) is a biotechnology company that develops differentiated human antibody therapeutics for the treatment of cancer. The company's marketed antibody, ofatumumab (Arzerra) and Daratumumab (Darzalex) are used to treat chronic lymphocyti...
  • Company Reports
  • Life Sciences
  • Denmark
  • $125.00
  • Report 05IC-GDPH34571FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH34571FSA
  • View Report: Research and Experts Company Reports: Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review

    Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review


    2017-03-15
    Teva Pharmaceutical Industries Ltd (Teva) carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines in central nervous system (CNS), respiratory, cancer, women’s health...
  • Company Reports
  • Life Sciences
  • Israel
  • $125.00
  • Report 05IC-GDPH33504FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH33504FSA
  • View Report: Research and Experts Market Report: Asthma Global Clinical Trials Review, H2, 2015

    Asthma Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Asthma Global Clinical Trials Review, H2, 2015" provides an overview of Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Asthma. Report includes...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2984CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC2984CTIDB
  • View Report: Research and Experts Market Report: Exercise-Induced Bronchoconstriction (EBI) Global Clinical Trials Review, H2, 2015

    Exercise-Induced Bronchoconstriction (EBI) Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Exercise-Induced Bronchoconstriction (EBI) Global Clinical Trials Review, H2, 2015" provides an overview of Exercise-Induced Bronchoconstriction (EBI) clinical trials scenario. This report provides top...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2962CTIDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IC-GDHC2962CTIDB
  • View Report: Research and Experts Market Report: Inhalers - Medical Devices Pipeline Assessment, 2015

    Inhalers - Medical Devices Pipeline Assessment, 2015


    2015-12-09
    GlobalData's Medical Devices sector report, “Inhalers - Medical Devices Pipeline Assessment, 2015" provides an overview of Inhalers currently in pipeline stage.

    The report provides comprehensive information on the pipeline products with...

  • Market Report
  • Medical Devices
  • Global
  • $4,000.00
  • Report 05IC-GDME0125EPD has a star rating of 3.7 out of 5
  • Go to More information on Report 05IC-GDME0125EPD
  • View Report: Research and Experts Market Report: Amenorrhea Global Clinical Trials Review, H2, 2015

    Amenorrhea Global Clinical Trials Review, H2, 2015


    2015-12-09
    GlobalData's clinical trial report, “Amenorrhea Global Clinical Trials Review, H2, 2015" provides an overview of Amenorrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Amenorrhea. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3051CTIDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IC-GDHC3051CTIDB
  • View Report: Research and Experts Market Report: Hormonal Contraception Global Clinical Trials Review, H2, 2015

    Hormonal Contraception Global Clinical Trials Review, H2, 2015


    2015-12-04
    GlobalData's clinical trial report, “Hormonal Contraception Global Clinical Trials Review, H2, 2015" provides an overview of Hormonal Contraception clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3030CTIDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IC-GDHC3030CTIDB
  • View Report: Research and Experts Market Report: Inflammatory Skin Diseases Global Clinical Trials Review, H2, 2015

    Inflammatory Skin Diseases Global Clinical Trials Review, H2, 2015


    2015-11-30
    GlobalData's clinical trial report, “Inflammatory Skin Diseases Global Clinical Trials Review, H2, 2015" provides an overview of Inflammatory Skin Diseases clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3017CTIDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IC-GDHC3017CTIDB
  • View Report: Research and Experts Market Report: Skin Infections Global Clinical Trials Review, H2, 2015

    Skin Infections Global Clinical Trials Review, H2, 2015


    2015-11-30
    GlobalData's clinical trial report, “Skin Infections Global Clinical Trials Review, H2, 2015" provides an overview of Skin Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Skin Infections...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3016CTIDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IC-GDHC3016CTIDB
  • View Report: Research and Experts Market Report: Organophosphate And Carbamate Poisoning Global Clinical Trials Review, H2, 2015

    Organophosphate And Carbamate Poisoning Global Clinical Trials Review, H2, 2015


    2015-11-30
    GlobalData's clinical trial report, “Organophosphate And Carbamate Poisoning Global Clinical Trials Review, H2, 2015" provides an overview of Organophosphate And Carbamate Poisoning clinical trials scenario. This report provides top line...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3014CTIDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IC-GDHC3014CTIDB
  • View Report: Research and Experts Market Report: Active Pharmaceutical Ingredients/API Market - Forecast to 2021

    Active Pharmaceutical Ingredients/API Market - Forecast to 2021


    2017-01-10
    The active pharmaceutical ingredients market in terms of value is expected to reach USD 213.97 billion by 2021 from USD 157.95 billion in 2016, growing at a CAGR of 6.3% from 2016 to 2021. This market is categorized on the basis of type, type of manufactu...
  • Market Report
  • Pharmaceuticals
  • Global
  • $5,650.00
  • Report 01L7-PH1262 has a star rating of 4.6 out of 5
  • Go to More information on Report 01L7-PH1262
  • View Report: Research and Experts Industry Report: Rx-OTC Switch Opportunities : Trends in OTC, category analysis, case studies and future opportunities

    Rx-OTC Switch Opportunities : Trends in OTC, category analysis, case studies and future opportunities


    2015-02-28
    After years of buoyant growth, the pharmaceutical industry is facing up to a more challenging time. With the growing cost of developing novel drugs, combined with rising regulatory pressures, the use of lifecycle management is playing an ever-more importa...
  • Industry Report
  • Cosmetics and Personal Care
  • Global
  • $2,795.00
  • Report 01GZ-CS1005IS has a star rating of 2.7 out of 5
  • Go to More information on Report 01GZ-CS1005IS
  • View Report: Research and Experts Industry Report: Global & USA BioSimilar Market Analysis to 2021; BioBetters, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte Colony-Stimulating...

    Global & USA BioSimilar Market Analysis to 2021; BioBetters, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte Colony-Stimulating Factor (G-CSF), Anti-Tumor Necrosis Factor (Anti-TNF), Monoclonal Antibodies (MAbs), Insulins, Interferons, Produ


    2015-08-01
    Biosimilars are highly-similar versions of biological drugs that are indicated for cancer, kidney disorders and a wide range of autoimmune diseases. Originator biologics are the most expensive drugs in the pharmaceutical industry and many of them cost...
  • Industry Report
  • Biopharmaceuticals
  • Global
  • $3,400.00
  • Report 01B7-2015BM has a star rating of 3.7 out of 5
  • Go to More information on Report 01B7-2015BM
  • View Report: Research and Experts Market Report: Biosimilars Market - Forecast to 2021

    Biosimilars Market - Forecast to 2021


    2017-01-05
    Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application (Oncology, Blood Disorders) - Global Forecast...
  • Market Report
  • Biotechnology
  • Global
  • $5,650.00
  • Report 01L7-BT2160 has a star rating of 4.3 out of 5
  • Go to More information on Report 01L7-BT2160
  • View Report: Research and Experts Industry Report: Apoptosis

    Apoptosis


    2015-10-01
    Apoptosis Market research report gives an insight into Apoptosis Mechanism, by Molecular Pathways, Caspase Activators and Inhibitors, Protease/Proteasome Inhibitors, Bcl-2 Modulators, p53 Modulators and Other. The study also focuses on major diseases...
  • Industry Report
  • Biotechnology
  • Global
  • $5,400.00
  • Report 05HF-RITMIR008 has a star rating of 4.0 out of 5
  • Go to More information on Report 05HF-RITMIR008
  • View Report: Research and Experts Industry Report: GLOBAL TRANSDERMAL DRUG DELIVERY MARKET TO 2020  <br />
Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation,...

    ' target='_blank'>GLOBAL TRANSDERMAL DRUG DELIVERY MARKET TO 2020
    Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation'


    2015-02-13
    This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 320 tables & figures over 280 pages. This report is presented...
  • Industry Report
  • Therapeutics Pharmacology
  • Global
  • $3,400.00
  • Report 01B7-2015TDDM has a star rating of 3.3 out of 5
  • ' target='_blank' >Go to More information on Report 01B7-2015TDDM
  • View Report: Research and Experts Industry Report: European Injectable Drug Delivery  - Forecast to 2020

    European Injectable Drug Delivery - Forecast to 2020


    2015-07-28
    The European injectable drug delivery market is expected to reach $207.3 billion by 2020 from $114.7 billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. The market is categorized on the basis of type, therapeutic application, usage pattern,...
  • Industry Report
  • Red Biotechnology
  • Global
  • $5,650.00
  • Report 01L7-BT2073 has a star rating of 3.3 out of 5
  • Go to More information on Report 01L7-BT2073
  • View Report: Research and Experts Company Reports: Teva Pharmaceutical Industries Limited : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report

    Teva Pharmaceutical Industries Limited : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report


    2013-01-30
    ICD Research's "Teva Pharmaceutical Industries Limited : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a...
  • Company Reports
  • Pharmaceuticals
  • Israel
  • $125.00
  • Report 01H3-SW1932CP has a star rating of 2.5 out of 5
  • Go to More information on Report 01H3-SW1932CP
  • Industries and Sectors

    • Healthcare (9)
    • Gastrointestinal... (1)
    • Oncology (15)
    • Infectious Disease... (1)
    • Central Nervous... (25)
    • Manufacturing and... (2)
    • Cardiovascular (3)
    • Pharmaceuticals (95)
    • Immunology (5)
    • Life Sciences (69)
    • Respiratory (5)
    • In Vitro Diagnostics... (1)
    • Non Specified Industry... (3)
    • Medical Devices (8)
    • Generic Drugs (20)
    • Construction Materials... (14)
    • Cosmetics and Personal... (1)
    • Biopharmaceuticals... (1)
    • Biotechnology (2)
    • Therapeutics Pharmacology... (1)
    • Red Biotechnology... (1)

    Geographic Regions

    • Global (232)
    • Israel (7)
    • United States (12)
    • India (3)
    • Germany (3)
    • Ireland (3)
    • Scandinavia (1)
    • North America (1)
    • Europe (1)
    • Asia Pacific (1)
    • United Kingdom (4)
    • Spain (1)
    • Netherlands (1)
    • Italy (1)
    • France (1)
    • Australia (1)
    • South Korea (1)
    • Singapore (1)
    • Japan (1)
    • China (1)
    • Mexico (1)
    • Canada (1)
    • South Africa (1)
    • Russian Federation... (1)
    • Denmark (1)

    Report Types

    • Market Report (226)
    • Project Profile (2)
    • Company Reports (28)
    • Industry Report (26)

    Return to Company List

    Page created and rendered - Cache updated [6.21734s]

    --